glp-1 impact on bariatric surgery Medication vs. for Weight Loss: Options Matter GLP-1 vs Bariatric Surgery Study:

One small study showed participants consuming ACV lost slightly more weight than a control group over 12 weeks, but the difference amounted to about 2-4 pounds

September 2025

The highest dose also helped patients with a body mass index of 35 or above who participated in an extension of the study lose 30.3% of their weight on average over 104 weeks

Remarkably, cognitive improvements were most noticeable in individuals with a higher body mass index or obesity

This reinforces the message that they should be screened regularlyannually for very stable individuals and every 3 or 6 months if they are at higher risk

Clinical studies have shown that people can lose a meaningful percentage of their body weight when combining the medication with lifestyle changes like improved diet and regular physical activity